These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34689307)

  • 1. The centrally restricted diffusion sign on MRI for assessment of radiation necrosis in metastases treated with stereotactic radiosurgery.
    Hainc N; Alsafwani N; Gao A; O'Halloran PJ; Kongkham P; Zadeh G; Gutierrez E; Shultz D; Krings T; Alcaide-Leon P
    J Neurooncol; 2021 Dec; 155(3):325-333. PubMed ID: 34689307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence.
    Puac-Polanco P; Zakhari N; Miller J; McComiskey D; Thornhill RE; Jansen GH; Nair VJ; Nguyen TB
    Can Assoc Radiol J; 2023 Feb; 74(1):100-109. PubMed ID: 35848632
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic Accuracy of Centrally Restricted Diffusion in the Differentiation of Treatment-Related Necrosis from Tumor Recurrence in High-Grade Gliomas.
    Zakhari N; Taccone MS; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Nguyen TB
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):260-264. PubMed ID: 29217742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSC Perfusion MRI-Derived Fractional Tumor Burden and Relative CBV Differentiate Tumor Progression and Radiation Necrosis in Brain Metastases Treated with Stereotactic Radiosurgery.
    Kuo F; Ng NN; Nagpal S; Pollom EL; Soltys S; Hayden-Gephart M; Li G; Born DE; Iv M
    AJNR Am J Neuroradiol; 2022 May; 43(5):689-695. PubMed ID: 35483909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery.
    Stockham AL; Tievsky AL; Koyfman SA; Reddy CA; Suh JH; Vogelbaum MA; Barnett GH; Chao ST
    J Neurooncol; 2012 Aug; 109(1):149-58. PubMed ID: 22638727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor habitat analysis by magnetic resonance imaging distinguishes tumor progression from radiation necrosis in brain metastases after stereotactic radiosurgery.
    Lee DH; Park JE; Kim N; Park SY; Kim YH; Cho YH; Kim HS
    Eur Radiol; 2022 Jan; 32(1):497-507. PubMed ID: 34357451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical model-based parameters to classify tumor recurrence from radiation-induced necrosis for brain metastases.
    Narasimhan S; Johnson HB; Nickles TM; Miga MI; Rana N; Attia A; Weis JA
    Med Phys; 2019 May; 46(5):2487-2496. PubMed ID: 30816555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centrally Reduced Diffusion Sign for Differentiation between Treatment-Related Lesions and Glioma Progression: A Validation Study.
    Alcaide-Leon P; Cluceru J; Lupo JM; Yu TJ; Luks TL; Tihan T; Bush NA; Villanueva-Meyer JE
    AJNR Am J Neuroradiol; 2020 Nov; 41(11):2049-2054. PubMed ID: 33060101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of Lesions after Stereotactic Radiosurgery for Brain Metastases: Impact of Delayed Contrast Magnetic Resonance Imaging.
    Wagner S; Gufler H; Eichner G; Lanfermann H
    Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):143-150. PubMed ID: 27777145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery in patients with multiple brain metastases.
    Chang SD; Lee E; Sakamoto GT; Brown NP; Adler JR
    Neurosurg Focus; 2000 Aug; 9(2):e3. PubMed ID: 16836289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigating the role of delayed contrast magnetic resonance imaging (MRI) to differentiate radiation necrosis from tumour recurrence in brain metastases after stereotactic radiosurgery.
    Admojo L; Korte J; Anderson N; Phillips C; Caspersz L; Lasocki A
    J Med Imaging Radiat Oncol; 2023 Apr; 67(3):292-298. PubMed ID: 36650724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images.
    Zhang Z; Yang J; Ho A; Jiang W; Logan J; Wang X; Brown PD; McGovern SL; Guha-Thakurta N; Ferguson SD; Fave X; Zhang L; Mackin D; Court LE; Li J
    Eur Radiol; 2018 Jun; 28(6):2255-2263. PubMed ID: 29178031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.